Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives
- Conditions
- HypertensionObesity
- Registration Number
- NCT00539487
- Lead Sponsor
- Boehringer Ingelheim
- Brief Summary
This observational non-interventional study will assess (under conditions of clinical practice in daily routine) the antihypertensive efficacy of telmisartan treatment with or without active promotion of lifestyle changes in hypertensive patients at high cardiovascular risk
- Detailed Description
Study Design:
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5827
patients with essential hypertension aged >/= 18 years with one of the following risk factors: history of coronary artery disease or stroke/TIA or peripheral artery disease or diabetes mellitus.
according to SPC
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure reduction 4 month
- Secondary Outcome Measures
Name Time Method Change in metabolic parameters Safety
Trial Locations
- Locations (94)
Boehringer Ingelheim Investigational Site 1
🇩🇪Übach-Palenberg, Germany
Boehringer Ingelheim Investigational Site 2
🇩🇪Übach-Palenberg, Germany
Boehringer Ingelheim Investigational Site 3
🇩🇪Zwickau, Germany
Boehringer Ingelheim Investigational Site 4
🇩🇪Zwickau, Germany
Boehringer Ingelheim Investigational Site 5
🇩🇪Zwickau, Germany
Boehringer Ingelheim Investigational Site 6
🇩🇪Zwickau, Germany
Boehringer Ingelheim Investigational Site 7
🇩🇪Zwickau, Germany
Boehringer Ingelheim Investigational Site 8
🇩🇪Wolfsburg, Germany
Boehringer Ingelheim Investigational Site
🇩🇪Ühlingen-Birkendorf, Germany
Boehringer Ingelheim Investigational Site 10
🇩🇪Wiesbaden, Germany
Scroll for more (84 remaining)Boehringer Ingelheim Investigational Site 1🇩🇪Übach-Palenberg, Germany